I adskillige kontrollerede studier har epoetiner ikke vist at kunne forbedre total overlevelse eller mindske risikoen for tumorprogression hos patienter, der har anæmi i forbindelse med cancer.
In several controlled studies, epoetins have not been shown to improve overall survival or decrease the risk of tumour progression in patients with anaemia associated with cancer.